Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seagen Inc (SGEN)  
$228.74 0.00 (0.00%) as of 4:30 Wed 12/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 180,310,000
Market Cap: 41.24(B)
Last Volume: 799,597 Avg Vol: 864,930
52 Week Range: $191.51 - $228.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 39,326 484,602
Total Sell Value $0 $0 $8,245,949 $88,100,996
Total People Sold 0 0 7 8
Total Sell Transactions 0 0 18 70
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 1805
  Page 43 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Simpson Todd E Chief Financial Officer   •       –      –    2013-03-07 4 OE $11.09 $244,610 D/D 20,176 133,451     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-03-06 4 S $30.42 $1,520,955 D/D (50,000) 122,948     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-03-06 4 OE $12.00 $600,000 D/D 50,000 172,948     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-03-05 4 S $28.95 $363,815 D/D (12,567) 122,948     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-03-05 4 OE $12.16 $152,815 D/D 12,567 135,515     -
   Siegall Clay B President and CEO   •       •      –    2013-03-05 4 AS $28.87 $1,984,950 D/D (68,750) 1,077,211     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-03-04 4 S $28.95 $1,083,685 D/D (37,433) 122,948     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-03-04 4 OE $12.16 $455,185 D/D 37,433 160,381     -
   Siegall Clay B President and CEO   •       •      –    2013-03-01 4 AS $28.12 $764,067 D/D (27,000) 1,145,961     -
   Siegall Clay B President and CEO   •       •      –    2013-03-01 4 OE $10.33 $20,660 D/D 2,000 1,172,961     -
   Gryska David W Director   –       •      –    2013-02-26 4 OE $5.00 $66,900 D/D 10,000 18,500     -
   Gryska David W Director   –       •      –    2013-02-25 4 S $27.17 $271,700 D/D (10,000) 8,500     -
   Siegall Clay B President and CEO   •       •      –    2013-02-01 4 AS $29.61 $59,216 D/D (2,000) 1,170,961     -
   Siegall Clay B President and CEO   •       •      –    2013-02-01 4 OE $10.33 $20,660 D/D 2,000 1,172,961     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2013-01-28 4 AS $30.19 $157,188 D/D (5,207) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2013-01-28 4 OE $12.00 $62,900 D/D 5,207 60,205     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2013-01-25 4 AS $29.84 $62,155 D/D (2,083) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2013-01-25 4 OE $15.46 $32,203 D/D 2,083 59,684     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2013-01-15 4 AS $28.00 $3,502,526 D/D (125,079) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2013-01-15 4 OE $11.09 $1,452,804 D/D 125,079 61,768     -
   Siegall Clay B President and CEO   •       •      –    2013-01-04 4 AS $25.05 $50,104 D/D (2,000) 1,170,961     -
   Siegall Clay B President and CEO   •       •      –    2013-01-04 4 OE $10.33 $20,660 D/D 2,000 1,172,961     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-01-04 4 AS $24.95 $1,272,026 D/D (50,983) 122,846     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2013-01-04 4 OE $11.09 $665,400 D/D 60,000 173,829     -
   Siegall Clay B President and CEO   •       •      –    2013-01-02 4 AS $23.83 $148,939 D/D (6,249) 1,170,961     -
  1805 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 43 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us